Comments

MannKind Stock Price, Quotes and Forecasts

Q: What sector and industry does MannKind (MNKD) operate in?

MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MNKDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$4.37

-0.01000-0.23%

At close: -

$4.41

0.040.92%

After Hours: 5:07 PM EDT

MannKind (MNKD) Forecast

News Earnings MannKind (MNKD) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

MannKind Stock Price, Quotes and Forecasts | NASDAQ:MNKD | Benzinga

Explore MannKind stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MNKD.

Open	$4.44
Close	$4.37
Volume / Avg.	1.60M / 1.95M
Day Range	$4.36 - $4.48
52 Wk Range	4.05 - 7.63
Market Cap	$1.34B
P/E Ratio	43.80
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	8.62%
Days to Cover	14.86

Recent News

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

MannKind Shares Are falling Today: What's Going On?

MannKind Corporation (NASDAQ: MNKD) are trading lower Monday. The company released its six-month results from its Phase 3 INHALE-1 pediatric diabetes trial. Here's what you need to know.

Vaishali Prayag

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.44
Close	$4.37
Volume / Avg.	1.60M / 1.95M
Day Range	$4.36 - $4.48
52 Wk Range	4.05 - 7.63
Market Cap	$1.34B
P/E Ratio	43.80
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	8.62%
Days to Cover	14.86

About Mannkind Corp

Sector

Health Care

Industry

Biotechnology

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inh...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MannKind (MNKD) stock?

You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.

View our list of the best stock brokerages

Who are MannKind (MNKD) competitors?

Other companies in MannKind’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX) and Arcutis Biotherapeutics (NASDAQ:ARQT).

What is the forecast, or price target, for MannKind (MNKD) stock?

MannKind has a consensus price target of $8.90.

What is the current price for MannKind (MNKD)?

The stock price for MannKind (NASDAQ: MNKD) is $4.41 last updated June 9, 2025 at 5:07 PM EDT.

Does MannKind (MNKD) pay a dividend?

There are no upcoming dividends for MannKind.

When is MannKind (NASDAQ:MNKD) reporting earnings?

MannKind’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is MannKind (MNKD) going to split?

There is no upcoming split for MannKind.

What sector and industry does MannKind (MNKD) operate in?

MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.